Protalix BioTherapeutics, Inc. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
At the Market Offering Agreement, dated February 27, 2023, between the Company and H.C. Wainwright & Co., LLC
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2023
Letter Agreement dated August 29, 2022 from Chiesi Farmaceutici S.p.A to Protalix Ltd
Protalix BioTherapeutics, Inc.
Biotechnology
2022
Fill/Finish Agreement effective on August 29, 2022 made by and between Chiesi Farmaceutici S.p.A and Protalix Ltd
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2022
Letter Amendment dated May 2, 2022
Protalix BioTherapeutics, Inc.
Biotechnology
2022
At the Market Offering Agreement, dated July 2, 2021, between the Company and H.C. Wainwright & Co., LLC
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Amended and Restated Agreement between Protalix Ltd. and Comercio e Servios Ltda. dated June 17, 2013
Protalix BioTherapeutics, Inc.
Biotechnology
2021
Exhibit A
Protalix BioTherapeutics, Inc.
Biotechnology
2014
AGREEMENT
Protalix BioTherapeutics, Inc.
Biotechnology
2014
Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2011
AGREEMENT made and signed on this 14 day of September, 2006
Protalix BioTherapeutics, Inc.
Biotechnology
2007
RESEARCH AND LICENCE AGREEMENT
Protalix BioTherapeutics, Inc.
Biotechnology
2007
SCIENTIFICADVISORY BOARD AGREEMENT
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2007
EX-10.8 Agreement between Teva and Protalix
Protalix BioTherapeutics, Inc.
Biotechnology
2007